{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T20:36:19Z","timestamp":1754598979318,"version":"3.37.3"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>This research is relevant, as AL-amyloidosis refers to a systemic type of disease characterized by aggregation of an improperly folded light chain of an immunoglobulin, mainly in the heart and kidneys, causing organ failure. This study describes the clinical experience of introducing a patient with cardiac amyloidosis associated with multiple myeloma (MM). A clinical case of a patient diagnozed with amyloidosis was considered. Magnetic resonance imaging signs of cardiac amyloidosis were confirmed due to the presence of concentric biventricular hypertrophy without dilation, atrial septal hypertrophy, a tendency to atrial dilation, thickening of valve flaps and atrial walls. Upon admission to the research institute, the patient had an anasarca. More accurate recognition of AL-amyloidosis by cardiologists allows for prescribing earlier treatment and improving results. Conventional treatment of MM and AL-amyloidosis includes a combination of dexamethasone with bortezomib and endoxan. Haematopoietic stem cell transplantation after taking high doses of melphalan has become another treatment option and has led to remission in some patients. The novelty of the study is that an example of a timely complete diagnosis and treatment of a combination of these two diseases was presented, as a result of which the patient has achieved a complete haematological and partial organ response to the underlying disease.<\/jats:p>","DOI":"10.1093\/carcin\/bgad004","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T12:40:39Z","timestamp":1674045639000},"page":"46-53","source":"Crossref","is-referenced-by-count":2,"title":["Outcome of clinical experience of introducing a patient with secondary systemic AL-amyloidosis associated with multiple myeloma"],"prefix":"10.1093","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0434-8496","authenticated-orcid":false,"given":"Olga","family":"Novosad","sequence":"first","affiliation":[{"name":"Department of Oncohematology, National Cancer Institute , Kyiv , Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tymur","family":"Rudiuk","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Bogomolets National Medical University , Kyiv , Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesya","family":"Shevchuk","sequence":"additional","affiliation":[{"name":"Department of Radiology Diagnostics with X-ray Rooms, National Cancer Institute , Kyiv , Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoriia","family":"Kundina","sequence":"additional","affiliation":[{"name":"Department of Radiology, Shupyk National Healthcare University of Ukraine , Kyiv , Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Pathology of the Myocardium and Transplant, Heart Institute of the Ministry of Health of Ukraine , Kyiv , Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"year":"2020","author":"Amyloidosis.","key":"2023051504235098900_CIT0001"},{"key":"2023051504235098900_CIT0002","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/leu.2012.100","article-title":"Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis","volume":"26","author":"Comenzo","year":"2012","journal-title":"Leukemia"},{"key":"2023051504235098900_CIT0003","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/bjh.12286","article-title":"Systemic amyloidosis in England: an epidemiological study","volume":"161","author":"Pinney","year":"2013","journal-title":"Br. J. Haemat."},{"key":"2023051504235098900_CIT0004","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/ard.45.8.663","article-title":"Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis","volume":"45","author":"Laakso","year":"1986","journal-title":"Ann. Rheum. Dis."},{"key":"2023051504235098900_CIT0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/030097401316909512","article-title":"Survival study of rheumatoid arthritis patients in Madrid (Spain). A 9-year prospective follow-up","volume":"30","author":"Martinez","year":"2001","journal-title":"Scand. J. Rheumat."},{"key":"2023051504235098900_CIT0006","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/030097400750001770","article-title":"Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992","volume":"29","author":"Kvalvik","year":"2000","journal-title":"Scand. J. Rheumat."},{"key":"2023051504235098900_CIT0007","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1186\/1471-2458-12-974","article-title":"Incidence and survival in non-hereditary amyloidosis in Sweden","volume":"12","author":"Hemminki","year":"2012","journal-title":"BMC Publ. Health."},{"key":"2023051504235098900_CIT0008","doi-asserted-by":"crossref","first-page":"305.e1","DOI":"10.1016\/j.repc.2016.01.004","article-title":"Diagnostic approach to cardiac amyloidosis: a case report","volume":"35(","author":"Fernandes","year":"2016","journal-title":"Rev. Portug. de Cardiol."},{"key":"2023051504235098900_CIT0009","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/13506129.2010.526812","article-title":"Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis","volume":"17","author":"Sipe","year":"2010","journal-title":"Amyloid"},{"key":"2023051504235098900_CIT0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.bmt.1705395","article-title":"Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?","volume":"38","author":"Bahlis","year":"2006","journal-title":"Bone Marrow Transpl."},{"key":"2023051504235098900_CIT0011","doi-asserted-by":"crossref","first-page":"e000364","DOI":"10.1161\/JAHA.111.000364","article-title":"Updates in cardiac amyloidoses: a review","volume":"1","author":"Banypersad","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"2023051504235098900_CIT0012","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1200\/JCO.2013.50.8499","article-title":"Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis.","volume":"31","author":"Kourelis","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"2023051504235098900_CIT0013","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/(SICI)1097-0142(19980415)82:8<1501::AID-CNCR11>3.0.CO;2-8","article-title":"Primary systemic amyloidosis with delayed progression to multiple myeloma","volume":"82","author":"Rajkumar","year":"1998","journal-title":"Cancer"},{"key":"2023051504235098900_CIT0014","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"New Engl. J. Med."},{"key":"2023051504235098900_CIT0015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J. Clin. Epidemiol."},{"key":"2023051504235098900_CIT0016","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41408-018-0080-9","article-title":"Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018","volume":"8","author":"Gertz","year":"2018","journal-title":"Blood Cancer J."},{"key":"2023051504235098900_CIT0017","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0025-6196(12)65706-1","article-title":"Primary systemic amyloidosis \u2013 a diagnostic primer","volume":"64","author":"Gertz","year":"1989","journal-title":"Mayo Clin. Proceed."},{"key":"2023051504235098900_CIT0018","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1750-1172-7-54","article-title":"AL amyloidosis","volume":"7","author":"Desport","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"2023051504235098900_CIT0019","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2215\/CJN.02740806","article-title":"Light-chain (AL) amyloidosis: diagnosis and treatment","volume":"1","author":"Sanchorawala","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2023051504235098900_CIT0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0339(200103)24:3<181::AID-DC1037>3.0.CO;2-D","article-title":"Abdominal fat pad aspiration biopsy for tissue confirmation of systemic amyloidosis: specificity, positive predictive value, and diagnostic pitfalls","volume":"24","author":"Guy","year":"2001","journal-title":"Diagn. Cytopathol"},{"key":"2023051504235098900_CIT0021","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2015141744","article-title":"Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study","volume":"277","author":"Fontana","year":"2015","journal-title":"Radiology"},{"key":"2023051504235098900_CIT0022","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk","year":"2005","journal-title":"Circulation"},{"key":"2023051504235098900_CIT0023","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0002-9149(02)02277-4","article-title":"Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis","volume":"89","author":"Koyama","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"2023051504235098900_CIT0024","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"key":"2023051504235098900_CIT0025","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"2023051504235098900_CIT0026","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","article-title":"Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis","volume":"135","author":"Maurer","year":"2017","journal-title":"Circulation"},{"key":"2023051504235098900_CIT0027","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/01.CIR.0000068313.67758.4F","article-title":"Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue doppler echocardiography in patients with AL (primary) cardiac amyloidosis","volume":"107","author":"Koyama","year":"2003","journal-title":"Circulation"},{"key":"2023051504235098900_CIT0028","first-page":"76","article-title":"Metabolic processes of organism in remote period after the combined effects of radiation and emotional stress","volume":"1","author":"Ilderbayeva","year":"2016","journal-title":"Georg. Med. News."},{"year":"2010","author":"Dolzhenko","key":"2023051504235098900_CIT0029"},{"key":"2023051504235098900_CIT0030","first-page":"599","article-title":"Possibilities of study of the main cytokines of the immune system in patients with osteogenic sarcoma","volume":"59","author":"Navruzov","year":"2013","journal-title":"Vopr. Onkol."},{"key":"2023051504235098900_CIT0031","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"key":"2023051504235098900_CIT0032","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"2023051504235098900_CIT0033","doi-asserted-by":"crossref","first-page":"761424","DOI":"10.3389\/fnhum.2021.761424","article-title":"Relating global and local connectome changes to dementia and targeted gene expression in Alzheimer\u2019s Disease","volume":"15","author":"Elsheikh","year":"2021","journal-title":"Front. Hum. Neurosci."},{"key":"2023051504235098900_CIT0034","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium en-hancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"2023051504235098900_CIT0035","first-page":"1267","article-title":"Prognostic value of late gadolinium enhancement CMR in systemic amyloidosis","volume":"9","author":"Raina","year":"2016","journal-title":"JACC: Cardiovasc. Imaging"},{"key":"2023051504235098900_CIT0036","first-page":"282","article-title":"The character of distribution of HLA specificities in oncological patients","volume":"62","author":"Burkitbaev","year":"2017","journal-title":"Klinichesch. Laborator. Diagn."},{"key":"2023051504235098900_CIT0037","first-page":"392","article-title":"Assessment and treatment of postoperative pain in children","volume":"22","author":"Dmytriiev","year":"2018","journal-title":"Anaesth. Pain Intens. Care"},{"key":"2023051504235098900_CIT0038","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol."},{"key":"2023051504235098900_CIT0039","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/joim.12585","article-title":"One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition","volume":"281","author":"Suhr","year":"2017","journal-title":"J. Intern. Med."},{"key":"2023051504235098900_CIT0040","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"2023051504235098900_CIT0041","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood.2019004460","article-title":"Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA","volume":"136","author":"Palladini","year":"2020","journal-title":"Blood"},{"key":"2023051504235098900_CIT0042","first-page":"247","article-title":"Right heart changes impact on clinical phenotype of amyloid cardiac involvement: a single centre study","volume":"18","author":"Cicco","year":"2020","journal-title":"Life (Basel)"},{"key":"2023051504235098900_CIT0043","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11739-011-0647-y","article-title":"Cardiac amyloidosis: the heart of the matter","volume":"8","author":"Perfetto","year":"2013","journal-title":"Intern. Emerg. Med."}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/carcin\/advance-article-pdf\/doi\/10.1093\/carcin\/bgad004\/49196284\/bgad004.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/carcin\/article-pdf\/44\/1\/46\/50314151\/bgad004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/carcin\/article-pdf\/44\/1\/46\/50314151\/bgad004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T04:24:34Z","timestamp":1684124674000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/44\/1\/46\/6994133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,20]]},"published-print":{"date-parts":[[2023,5,15]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgad004","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"type":"print","value":"0143-3334"},{"type":"electronic","value":"1460-2180"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2023,1,1]]}}}